세계로 도약하는 항암면역세포치료제 최고의 세포배양기술과 설비로 앞선 면역세포치료제 개발을 통하여 미래 의학 구현의 선구자로 자리매김하고 있습니다.

임상시험현황

home 연구개발 개발진행현황

간암

Efficacy and Safety of Immune cell Therapy Group and Non-treatment Group in Hepatocelluar Carcinoma Patients

phase:phase3(3상 임상시험) 바로가기

임상시험
locations Seoul National University Hospital
Seoul, Korea, Republic of
Principal Investigator: Jung Hwan Yoon, MD
서울대학교병원 윤정환 교수
Samsung Medical Center
Seoul, Korea, Republic of
삼성서울병원 이준혁 교수
Seoul Asan Medical Center
Seoul, Korea, Republic of
서울아산병원 임영석 교수
Korea University Ansan Hospital
Gyeonggi-Do, Ansan, Korea, Republic of
고려대 안산병원 송태진 교수
Korea University Guro Hospital
Seoul, Korea, Republic of
고려대 구로병원 연종은 교수

Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients 바로가기


Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' With Nexavar in Advanced Hcc Patients

phase:phase2 바로가기

임상시험
locations Korea University Anam Hospital
Seoul, Korea, Republic of
Principal Investigator: Soon Ho Um, MD, PhD
고려대 안암병원 엄순호 교수
The Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul, Korea, Republic of
가톨릭대 서울성모병원 최종영 교수
Yonsei University Health System
Seoul, Korea, Republic of
연세대 세브란스병원 김도영 교수
Inha University Hospital
Incheon, Korea, Republic of
인하대병원 이진우 교수

Clinical Trial to Evaluate the Efficacy and Safety of "Immuncell-LC" in the Patients Undergone TACE for Intermediate Stage Hepatocellular Carcinoma

phase:phase2 바로가기

임상시험
locations Seoul National University Hospital
Seoul, Daehak-ro 101/Jongno-gu, Korea, Republic of
Principal Investigator: Jung Hwan Yoon, MD
서울대학교병원 윤정환 교수
Seoul St.Mary's Hospital Not yet recruiting
Seoul, Banpo-daero 222 / Seocho-go, Korea, Republic of
가톨릭대 서울성모병원 최종영 교수
Gangnam Severance Hospital Not yet recruiting
Seoul, Eonjuro 712 / Gangnam-gu, Korea, Republic of
Principal Investigator: Do Young Kim, MD, PhD
연세대 세브란스병원 김자경 교수

뇌종양

Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immune cell Therapy' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

phase:phase3(3상 임상시험) 바로가기

임상시험
locations Konkuk University
Seoul, Korea, Republic of
건국대병원 고영초 교수
Gyunghee University Medical Center
Seoul, Korea, Republic of
경희대병원 임영진 교수
Yeonsei University Medical Center
Seoul, Korea, Republic of
연세대 세브란스병원 장종희 교수
Samsung Seoul Medical Center
Seoul, Korea, Republic of
삼성서울병원 남도현 교수
Seoul Asan Medical Center
Seoul, Korea, Republic of
서울아산병원 김정훈 교수
Hanyang University Guri Hospital
Gyeonggi-Do, Guri, Korea, Republic of
한양대 구리병원 김충현 교수
Korea University Anam Hospital
Seoul, Korea, Republic of
고려대안암병원 정용구 교수

A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma

phase:Pilot Study 바로가기

예비연구
locations Seoul National University Hospital
Seoul, Korea, Republic of
Principal Investigator: Hee Young Shin, MD, Ph.D
서울대학교병원 신희영 교수

췌장암

Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer

phase:phase 바로가기

임상시험
locations Korea, Republic of Yonsei medical center
Seoul, Korea, Republic of
Principal Investigator: Siyong Song, MD, PhD
연세대 세브란스병원 송시영 교수